Total Liabilities Summary of Bavarian Nordic A/S

Bavarian Nordic A/S's latest annual total liabilities in 2023 was 4.01 Billion DKK , down -23.43% from previous year.
Bavarian Nordic A/S's latest quarterly total liabilities in 2024 Q2 was 3.83 Billion DKK , up 11.35% from previous quarter.
Bavarian Nordic A/S reported annual total liabilities of 5.24 Billion DKK in 2022, up 11.17% from previous year.
Bavarian Nordic A/S reported annual total liabilities of 4.71 Billion DKK in 2021, up 21.99% from previous year.
Bavarian Nordic A/S reported quarterly total liabilities of 3.44 Billion DKK for 2024 Q1, down -14.12% from previous quarter.
Bavarian Nordic A/S reported quarterly total liabilities of 4.01 Billion DKK for 2023 Q4, down -1.23% from previous quarter.

Annual Total Liabilities Chart of Bavarian Nordic A/S (2023 - 2001)

Historical Annual Total Liabilities of Bavarian Nordic A/S (2023 - 2001)

Year	Total Liabilities	Total Liabilities Growth
2023	4.01 Billion DKK	-23.43%
2022	5.24 Billion DKK	11.17%
2021	4.71 Billion DKK	21.99%
2020	3.86 Billion DKK	-25.41%
2019	5.18 Billion DKK	488.61%
2018	880.3 Million DKK	36.19%
2017	646.37 Million DKK	-19.85%
2016	806.46 Million DKK	24.69%
2015	646.78 Million DKK	1.83%
2014	635.17 Million DKK	33.46%
2013	475.91 Million DKK	-11.79%
2012	539.5 Million DKK	-29.84%
2011	768.98 Million DKK	17.1%
2010	656.69 Million DKK	15.84%
2009	566.89 Million DKK	-16.53%
2008	679.13 Million DKK	32.03%
2007	514.38 Million DKK	95.57%
2006	263.02 Million DKK	-11.87%
2005	298.46 Million DKK	4.1%
2004	286.71 Million DKK	248.93%
2003	82.16 Million DKK	-32.24%
2002	121.26 Million DKK	583.9%
2001	17.73 Million DKK	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	3.83 Billion DKK	11.35%
2024 Q1	3.44 Billion DKK	-14.12%
2023 Q4	4.01 Billion DKK	-1.23%
2023 Q2	5.3 Billion DKK	30.73%
2023 Q1	4.05 Billion DKK	-22.54%
2023 FY	4.01 Billion DKK	-23.43%
2023 Q3	4.06 Billion DKK	-23.44%
2022 Q1	4.86 Billion DKK	3.22%
2022 FY	5.24 Billion DKK	11.17%
2022 Q4	5.24 Billion DKK	-1.8%
2022 Q3	5.33 Billion DKK	3.65%
2022 Q2	5.14 Billion DKK	5.82%
2021 Q3	4.34 Billion DKK	3.01%
2021 Q1	3.82 Billion DKK	-0.96%
2021 Q2	4.21 Billion DKK	10.24%
2021 FY	4.71 Billion DKK	21.99%
2021 Q4	4.71 Billion DKK	8.46%
2020 Q4	3.86 Billion DKK	-7.7%
2020 FY	3.86 Billion DKK	-25.41%
2020 Q1	3.89 Billion DKK	-24.84%
2020 Q2	3.99 Billion DKK	2.49%
2020 Q3	4.18 Billion DKK	4.9%
2019 Q2	685.45 Million DKK	1.6%
2019 Q4	5.18 Billion DKK	672.09%
2019 Q3	671.11 Million DKK	-2.09%
2019 FY	5.18 Billion DKK	488.61%
2019 Q1	674.66 Million DKK	-23.36%
2018 Q1	696.76 Million DKK	7.8%
2018 Q3	824.77 Million DKK	-8.94%
2018 Q4	880.3 Million DKK	6.73%
2018 FY	880.3 Million DKK	36.19%
2018 Q2	905.73 Million DKK	29.99%
2017 Q2	945.59 Million DKK	12.33%
2017 Q4	646.37 Million DKK	131.8%
2017 FY	646.37 Million DKK	-19.85%
2017 Q1	841.79 Million DKK	4.38%
2017 Q3	278.85 Million DKK	-70.51%
2016 Q3	668.32 Million DKK	-1.32%
2016 FY	806.46 Million DKK	24.69%
2016 Q4	806.46 Million DKK	20.67%
2016 Q2	677.23 Million DKK	4.16%
2016 Q1	650.17 Million DKK	0.52%
2015 Q4	646.78 Million DKK	-22.68%
2015 Q1	1.19 Billion DKK	88.14%
2015 Q2	871.8 Million DKK	-27.05%
2015 FY	646.78 Million DKK	1.83%
2015 Q3	836.47 Million DKK	-4.05%
2014 FY	635.17 Million DKK	33.46%
2014 Q1	353.7 Million DKK	-25.68%
2014 Q2	330.2 Million DKK	-6.64%
2014 Q3	382.3 Million DKK	15.78%
2014 Q4	635.17 Million DKK	66.15%
2013 Q3	457.8 Million DKK	-13.87%
2013 FY	475.91 Million DKK	-11.79%
2013 Q1	427.7 Million DKK	-20.72%
2013 Q2	531.5 Million DKK	24.27%
2013 Q4	475.91 Million DKK	3.96%
2012 Q1	690.9 Million DKK	-10.15%
2012 Q4	539.5 Million DKK	-8.82%
2012 Q3	591.7 Million DKK	-11.63%
2012 FY	539.5 Million DKK	-29.84%
2012 Q2	669.6 Million DKK	-3.08%
2011 Q2	664 Million DKK	2.06%
2011 Q1	650.6 Million DKK	-0.93%
2011 Q4	768.98 Million DKK	19.0%
2011 Q3	646.2 Million DKK	-2.68%
2011 FY	768.98 Million DKK	17.1%
2010 Q1	542.7 Million DKK	-4.27%
2010 Q4	656.69 Million DKK	-2.76%
2010 Q3	675.3 Million DKK	-8.52%
2010 FY	656.69 Million DKK	15.84%
2010 Q2	738.2 Million DKK	36.02%
2009 Q4	566.89 Million DKK	0.0%
2009 FY	566.89 Million DKK	-16.53%
2008 FY	679.13 Million DKK	32.03%
2007 FY	514.38 Million DKK	95.57%
2006 FY	263.02 Million DKK	-11.87%
2005 FY	298.46 Million DKK	4.1%
2004 FY	286.71 Million DKK	248.93%
2003 FY	82.16 Million DKK	-32.24%
2002 FY	121.26 Million DKK	583.9%
2001 FY	17.73 Million DKK	0.0%

Peer Total Liabilities Comparison of Bavarian Nordic A/S

Name	Total Liabilities	Total Liabilities Difference
ALK-Abelló A/S	2.27 Billion DKK	-76.098%
Genmab A/S	3.67 Billion DKK	-9.086%
Gubra A/S	145.62 Million DKK	-2655.977%
Novo Nordisk A/S	207.92 Billion DKK	98.07%
Orphazyme A/S	5.07 Million DKK	-79057.416%
Pharma Equity Group A/S	42.4 Million DKK	-9364.393%
Zealand Pharma A/S	1.6 Billion DKK	-149.888%

Global Stocks Search

Bavarian Nordic A/S (BAVA.CO)

Total Liabilities Summary of Bavarian Nordic A/S

Annual Total Liabilities Chart of Bavarian Nordic A/S (2023 - 2001)

Historical Annual Total Liabilities of Bavarian Nordic A/S (2023 - 2001)

Peer Total Liabilities Comparison of Bavarian Nordic A/S